Please note that you are now entering a website directly or indirectly maintained by a third party (the "External Site") and that you do so at your own risk.

Please note that you are now entering a website directly or indirectly maintained by a third party (the "External Site") and that you do so at your own risk.

By clicking “Accept” you acknowledge and agree that neither ITGR nor third party provider Virtua Research, Inc. (“Virtua) is responsible, or accepts or assumes any responsibility or liability whatsoever for, the content, the data or the technical operation of the Linked Site. Further, by entering the External Site, you also acknowledge and agree that you completely and irrevocably waive any and all rights and claims against ITGR and Virtua and further acknowledge and agree that in no event shall ITGR or Virtua, its officers, employees, directors and agents be liable for any (i) indirect, consequential, incidental, special, compensatory or punitive damages, (ii) damages for loss of income, loss of business profits, business interruption, loss of data or business information, loss of or damage to property, (iii) claims of third parties, or (iv) other pecuniary loss, arising out of or related to this disclaimer or the External Site

By entering the External Site, you further acknowledge and agree that the disclaimer of warranties and limitations of liability set out in this disclaimer shall apply regardless of the causes, circumstances or form of action giving rise to the loss, damage, claim or liability, even if such loss, damage, claim or liability is based upon breach of contract (including, without limitation, a claim of fundamental breach or breach of a fundamental term), tort (including, without limitation, negligence), strict liability or any other legal or equitable theory, and even if ITGR and Virtua are advised of the possibility of the loss, damage, claim or liability. The waiver and release specifically includes, without limitation, any and all rights and claims pertaining to the processing of personal data, including but not limited to any rights under any applicable data protection statute(s).

If in any jurisdiction, any part of this disclaimer is held to be unenforceable by a court of competent jurisdiction, such part of this disclaimer shall be restricted or eliminated to the minimum extent and the remaining disclaimer shall otherwise remain in full force and effect.

Please note the information presented is deemed representative at the time of its original release. Changes in historical information may occur due to adjustments in accounting and reporting standards & procedures.

Non-GAAP Information

In addition to disclosing results determined in accordance with GAAP, ITGR may also disclose certain non-GAAP and pro forma non-GAAP results of operations, including certain ratios, operational and miscellaneous data, as well as net income, diluted earnings per share, operating expenses, and operating income that make certain adjustments or exclude certain charges and gains that are outlined in the schedules included in this website. Management believes that this non-GAAP and pro forma non-GAAP information provides investors with additional information to assess ITGR operating performance by making certain adjustments or excluding costs or gains and assists investors in comparing our operating performance to prior periods. Management uses this non-GAAP and pro forma non-GAAP information, along with GAAP information, in evaluating its historical operating performance. ITGR and Virtua also take no responsibility for third party pricing data provided for informational purposes and certain ratio results formulated from the provided third party pricing data.

The non-GAAP information is not prepared in accordance with GAAP and may not be comparable to non-GAAP information used by other companies. The non-GAAP information should not be viewed as a substitute for, or superior to, other data prepared in accordance with GAAP.

Integer to Showcase European Expansion, Commitment to Medical Device OEMs and Start-Ups at Compamed 2023

November 8, 2023

PLANO, Texas, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer and a complete partner in innovation, will exhibit at Compamed 2023 from November 13-16, in Düsseldorf, Germany. Integer can be found in Hall 8b / N29.

During Compamed, Integer looks forward to connecting with medical device OEMs and start-ups to discuss its comprehensive suite of solutions from prototype to pilot and beyond. Integer’s focal points for Compamed 2023 revolve around the company’s significant investments in Europe, particularly in Ireland.

Integer has recently undertaken a strategic expansion of its site in New Ross, Ireland, covering an additional 80,000 square feet to substantially increase its high-volume guidewire and wire-based manufacturing capacity. Alongside the New Ross expansion, Integer has also invested in a new R&D and manufacturing facility in Galway, Ireland. The first construction phase of this new facility will add approximately 70,000 square feet of R&D and manufacturing space. This expansion aims to provide local solutions for structural heart, neurovascular, and electrophysiology applications, enabling seamless transitions from R&D to operations.

Further amplifying the company’s presence in Ireland, Integer’s team of experts in Spiddal, Ireland, specializes in complex braiding, textile, and impact coating and covering capabilities. The team offers comprehensive solutions, including medical textiles, absorbable stents, and biomaterial braiding, among others.

“We are committed to delivering unparalleled value to our partners,” said Payman Khales, President, Cardio & Vascular. “With our recent expansions in Europe, we’re dramatically strengthening our local and global differentiated R&D and manufacturing capabilities. Our aim is to streamline the supply chain and ensure a smooth transition from R&D to operations for both our European and global customers, helping to accelerate time to market for new product innovations.”

Medical device OEMs, start-ups and all interested parties are invited to visit Hall 8b / N29 during Compamed from November 13-16, 2023, to learn more about how Integer can serve as your complete partner in innovation.

Learn more about Integer at www.integer.net.

About Integer ®
Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device outsource (MDO) manufacturers in the world serving the cardiac, neuromodulation, vascular, portable medical and orthopedics markets. The Company provides innovative, high-quality medical technologies that enhance the lives of patients worldwide. In addition, the Company develops batteries for high-end niche applications in energy, military, and environmental markets. The Company's brands include Greatbatch Medical®, Lake Region Medical® and Electrochem®. Additional information is available at www.integer.net

Investor Relations:
Andrew Senn
Media Relations:
Kelly Butler

Primary Logo

Source: Integer Holdings Corporation